Progress and Challenges of Predictive Biomarkers for Immune Checkpoint Blockade

Over the past decade, immune checkpoint blockade (ICB) therapy has revolutionized the outlook for oncology with significant and sustained improvement in the overall patient survival. Unlike traditional cancer therapies, which target the cancer cells directly, ICB acts on the immune system to enhance...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Yanna, Li, Xiaoying, Huang, Qian, Zheng, Xiufeng, Liu, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992906/
https://www.ncbi.nlm.nih.gov/pubmed/33777757
http://dx.doi.org/10.3389/fonc.2021.617335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992906/
https://www.ncbi.nlm.nih.gov/pubmed/33777757
http://dx.doi.org/10.3389/fonc.2021.617335

Ejemplares similares